GEORGES GEMAYEL
CIK 1256088 · Executive Chair of the Board · last filed 2026-06-23
GEORGES GEMAYEL is an Executive Chair of the Board who has filed 75 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for IRON, was dated Jun 23, 2026. Across all open-market trades the lifetime net is −$6.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.90M
10
75
-$6.06M
Filer Profile
BEDMINSTER, NJ 07921
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IRON | Director | — | $79.23 | — | $0 | 5 | 2026-06-23 |
| SUPN | Director | 28,159 | $43.53 | $1.23M | -$2.35M | 22 | 2026-03-09 |
| Disc Medicine, Inc. (GMTX) Delisted | Executive Chair of the Board | — | $13.50 | — | $0 | 3 | 2022-01-05 |
| MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Director | 0 | — | — | -$630.0K | 8 | 2020-10-01 |
| Dimension Therapeutics, Inc. (DMTX) Delisted | Director | — | — | — | $0 | 3 | 2017-11-07 |
| Raptor Pharmaceutical Corp (RPTP) Delisted | Director | 0 | — | — | $0 | 4 | 2016-10-26 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | Director | 0 | — | — | -$233.3K | 9 | 2015-02-24 |
| RPRX | Director | 1,852 | $63.96 | $118.5K | $0 | 5 | 2010-05-19 |
| Altus Pharmaceuticals Inc. (ALTU) Delisted | President & CEO | — | $10.12 | — | $0 | 4 | 2009-02-23 |
| GENZ | Executive Vice President | 14,090 | $39.48 | $556.3K | -$2.85M | 3 | 2007-11-02 |
Recent Filings
75 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-23 | IRON | Grant (A) | — | $0 | EDGAR |
| 2026-03-09 | SUPN | Mixed | −10,882 | -$802.8K | EDGAR |
| 2026-03-06 | SUPN | Notice (144) | −8,787 | -$465.8K | EDGAR |
| 2026-03-05 | SUPN | Notice (144) | −10,000 | -$537.1K | EDGAR |
| 2026-02-25 | SUPN | Mixed | +19,475 | $194.7K | EDGAR |
| 2026-02-20 | SUPN | Grant (A) | — | $0 | EDGAR |
| 2025-09-18 | IRON | Grant (A) | — | $0 | EDGAR |
| 2025-06-13 | IRON | Grant (A) | — | $0 | EDGAR |
| 2025-02-24 | SUPN | Mixed | +5,369 | $0 | EDGAR |
| 2025-02-21 | SUPN | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.